A production line for a radioactive liquid drug

By designing an automated production line for radioactive liquid drugs, and utilizing robotic arms and transfer channels to automate the production of iodine-131 oral solution, the problems of low production efficiency and inconsistent quality were solved, personnel risks were reduced, and an efficient and safe production process was achieved.

CN224981296UActive Publication Date: 2026-11-17SHANGHAI TOFFLON SCI & TECH CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202522078036.8
Authority / Receiving Office
CN · China
Patent Type
Utility models(China)
Current Assignee / Owner
Filing Date
2025-09-26
Publication Date
2026-11-17
Estimated Expiration
2035-09-26

AI Technical Summary

Technical Problem

Existing technologies for iodine-131 oral solution production suffer from low efficiency, high labor intensity, high risk, and difficulty in ensuring product quality consistency. They also lack automated equipment and a complete production process.

Method used

A radioactive liquid drug production line was designed, comprising a receiving hot chamber, a dilution hot chamber, and a dispensing hot chamber. The line utilizes robotic arms and transfer channels to automate the transfer, dilution, and dispensing of raw material bottles. The entire process is carried out within a highly protected hot chamber, minimizing manual operation.

Benefits of technology

It has improved production efficiency, ensured the consistency of product quality, reduced personnel burden and radiation risks, and achieved efficient and safe production of radiopharmaceuticals.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN224981296U_ABST
    Figure CN224981296U_ABST
Patent Text Reader

Abstract

This invention provides a production line for radioactive liquid drugs, including a receiving hot chamber, a dilution hot chamber, and a dispensing hot chamber. The receiving hot chamber is equipped with an opening mechanism for opening raw material bottles and a first robotic arm for transferring the raw material bottles to a first transfer channel. The dilution hot chamber is equipped with a second robotic arm and a dilution assembly. The second robotic arm transfers the raw material bottles into the dilution hot chamber. The dilution assembly is used to dilute the raw materials in the bottles to obtain a diluted solution. The dispensing hot chamber is equipped with a dispensing station for dispensing the diluted solution, which is connected to the dilution assembly via a capillary tube. This invention, by setting corresponding devices in multiple hot chambers with different functions, realizes the introduction, dilution, sampling, dispensing, and discharge of radioactive drugs. The entire production process is carried out under the protection of highly protective hot chambers, reducing reliance on production personnel. Therefore, it ensures both production efficiency and product quality consistency while reducing personnel burden and risks.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the field of radiopharmaceutical production, and more particularly to a production line for a radiopharmaceutical liquid production line. Background Technology

[0002] Iodine-131 oral solution is a liquid medicine containing the radioactive isotope iodine-131. It treats hyperthyroidism and thyroid cancer by releasing beta rays to destroy thyroid tissue or cancer cells. However, as a volatile radionuclide, iodine-131 has a complex production process, requiring a sealed, clean, and radiation-proof production environment. Currently, China lacks a complete production process and mature, highly automated equipment for iodine-131 production. Production relies heavily on manual operation in simple protective heated chambers, resulting in low production efficiency, high labor intensity and radiation risk for workers, and potential product quality fluctuations due to inconsistent manual operation. Summary of the Invention

[0003] This invention provides a production line for radioactive liquid drugs, aiming to improve the problems of low production efficiency, heavy personnel burden and high risk, and difficulty in ensuring product quality consistency in the artificial production of iodine-131 oral solution.

[0004] Specifically, the present invention provides a radioactive liquid drug production line, including a receiving hot chamber, a dilution hot chamber and a dispensing hot chamber, wherein the receiving hot chamber and the dilution hot chamber are connected through a first transfer channel; The receiving hot chamber is used to receive raw material bottles containing radioactive raw materials; the receiving hot chamber is provided with an opening mechanism for opening the raw material bottle and a first robotic arm for transferring the raw material bottle to the first transfer channel; The dilution heating chamber is equipped with a second robotic arm and a dilution assembly. The second robotic arm is used to transfer the raw material bottle into the dilution heating chamber; the dilution assembly is used to dilute the raw material in the raw material bottle to obtain a diluted solution. The dispensing hot chamber is equipped with a dispensing station for dispensing the diluent, and the dispensing station is connected to the dilution assembly via a capillary tube.

[0005] Optionally, the radioactive liquid drug production line further includes a transfer assembly for transferring the raw material bottle from the warehouse to the receiving heat chamber; The transfer assembly includes a trolley with a first shielding container on it, and the raw material bottle is placed inside the first shielding container.

[0006] Optionally, the bottom of the receiving hot chamber is provided with a raw material inlet; the receiving hot chamber is also provided with a third robotic arm for transferring the shielded container into the receiving hot chamber.

[0007] Optionally, the dilution chamber is further equipped with a detection system for detecting the concentration of radioactive material in the raw material bottle and calculating the required amount of dilution solution.

[0008] Optionally, the dilution chamber also contains a dilution sampling bottle for testing the dilution effect of the diluent; the dilution assembly is further configured to inject the diluent into the dilution sampling bottle.

[0009] Optionally, the radioactive liquid drug production line further includes a preparation hot chamber, which is connected to the dispensing hot chamber via a third transfer channel for supplying product vials to the dispensing hot chamber.

[0010] Optionally, the radioactive liquid drug production line further includes a discharge system, which includes a supply device, a robot system, and a transfer device. The supply device and the transfer device are arranged at intervals, and the robot system is arranged between the supply device and the transfer device. The bottom of the dispensing hot chamber is provided with a discharge port; a discharge platform is installed on the side of the dispensing hot chamber near the robot system, and a rotatable rotating guide rail is provided on the discharge platform, and a base is provided on the rotating guide rail. The supply device is used to carry the second shielding container, the robot system is used to transfer the second shielding container to the base, and to transfer the second shielding container with the product bottle on the base to the transfer device; when the base rotates to the point where the second shielding container is below the discharge port, the product bottle falls into the second shielding container.

[0011] Optionally, the dilution chamber is equipped with a waste liquid collection system, and the dilution component is connected to the waste liquid collection system through a first discharge pipe; the dispensing station is connected to the waste liquid collection system through a second discharge pipe.

[0012] The beneficial effects of this invention are as follows: In application, the production line for radioactive liquid drugs provided by this invention involves sending a raw material bottle containing radioactive material into a receiving hot chamber. A capping mechanism opens the bottle, and a first robotic arm transfers it to a first transfer channel. A second robotic arm in a dilution hot chamber transfers the bottle from the first transfer channel to the dilution hot chamber for dilution, yielding a diluted solution. The diluted solution then enters a dispensing station in a dispensing hot chamber via capillary tubes for dispensing, resulting in the final product. In other words, this invention, by setting up multiple sequentially connected hot chambers with different functions and corresponding devices within each chamber, realizes the introduction, dilution, sampling, dispensing, and discharge of radioactive drugs. The entire production process is carried out under the protection of highly shielded hot chambers, reducing reliance on production personnel. Therefore, it ensures both production efficiency and consistent product quality while reducing personnel burden and risks. Attached Figure Description

[0013] Figure 1 This is a schematic structural diagram of a production line for a radioactive liquid drug provided in an embodiment of the present invention; Figure 2 This is a schematic structural diagram of a transfer component in a production line provided by an embodiment of the present invention.

[0014] Explanation of reference numerals in the attached figures: 1. Transfer assembly; 101. Trolley; 102. First shielding container; 103. Raw material bottle; 2. Receiving hot chamber; 201. Raw material inlet; 202. Capping mechanism; 203. Third robotic arm; 204. Material transfer inlet; 205. First robotic arm; 206. First transfer channel; 207. Dilution sampling bottle; 3. Dilution hot chamber; 301. Dilution assembly; 302. First solid waste collection system; 303. Second robotic arm; 304. Fourth robotic arm; 305. Detection system; 306. Second transfer channel; 307. Capillary tube; 308. Waste liquid collection system; 309. First discharge pipe. 4. Packaging Hot Chamber, 401. Packaging Station, 402. Second Solid Waste Collection System, 403. Detection System, 404. Robot, 405. Fifth Robotic Arm, 406. Sixth Robotic Arm, 407. Third Transfer Channel, 408. Discharge Port, 409. Discharge Platform, 410. Rotary Guide Rail, 411. Base, 412. Second Discharge Pipe, 5. Preparation Hot Chamber, 501. Tray, 50101. Product Bottle, 502. Third Solid Waste Collection System, 6. Discharge System, 601. Supply Device, 60101. Second Shielding Container, 602. Robot System, 603. Transfer Device. Detailed Implementation

[0015] To make the technical problems solved, the technical solutions, and the beneficial effects of this invention clearer, the invention will be further described in detail below with reference to the accompanying drawings and embodiments. It should be understood that the specific embodiments described herein are merely illustrative of the invention and are not intended to limit the invention.

[0016] In the description of this invention, it should be understood that the terms "longitudinal," "radial," "length," "width," "thickness," "upper," "lower," "front," "rear," "left," "right," "vertical," "horizontal," "top," "bottom," "inner," and "outer," etc., indicating orientation or positional relationships, are based on the orientation or positional relationships shown in the accompanying drawings and are only for the convenience of describing the invention and simplifying the description, and do not indicate or imply that the device or element referred to must have a specific orientation, or be constructed and operated in a specific orientation, and therefore should not be construed as a limitation of the invention. In the description of this invention, unless otherwise stated, "a plurality of" means two or more.

[0017] In the description of this invention, it should be noted that, unless otherwise explicitly specified and limited, the terms "installation," "connection," and "linking" should be interpreted broadly. For example, they can refer to a fixed connection, a detachable connection, or an integral connection; they can refer to a mechanical connection or an electrical connection; they can refer to a direct connection or an indirect connection through an intermediate medium; and they can refer to the internal connection of two components. Those skilled in the art can understand the specific meaning of the above terms in this invention based on the specific circumstances.

[0018] Figure 1 This is a schematic structural diagram of a production line for a radioactive liquid drug according to an embodiment of the present invention. Figure 1 As shown, and with reference Figure 2 This invention provides a production line for a radioactive liquid drug, comprising a receiving hot chamber 2, a dilution hot chamber 3, and a dispensing hot chamber 4. The receiving hot chamber 2 and the dilution hot chamber 3 are connected via a first transfer channel 206. The receiving hot chamber 2 is used to receive a raw material bottle 103 containing radioactive raw materials. The receiving hot chamber 2 is provided with a capping mechanism 202 for opening the raw material bottle 103 and a first robotic arm 205 for transferring the raw material bottle 103 to the first transfer channel 206. The dilution hot chamber 3 is provided with a second robotic arm 303 and a dilution assembly 301. The second robotic arm 303 is used to transfer the raw material bottle 103 into the dilution hot chamber 3. The dilution assembly 301 is used to dilute the raw material in the raw material bottle 103 to obtain a diluted solution. The dispensing hot chamber 4 is provided with a dispensing station 401 for dispensing the diluted solution. The dispensing station 401 is connected to the dilution assembly 301 via a capillary tube 307.

[0019] It should be noted that a hot chamber is a facility specifically designed for handling radioactive materials and possesses the characteristics of shielding, sealing, ventilation, and isolation. In this embodiment, the receiving hot chamber 2, dilution hot chamber 3, dispensing hot chamber 4, and preparation hot chamber 5 (hereinafter referred to as the preparation hot chamber) are named according to their roles in the production line.

[0020] In this embodiment, by setting up multiple hot chambers with different functions and connected in sequence, and setting up corresponding devices in the hot chambers, the radiopharmaceutical is introduced, diluted, sampled, packaged and discharged. The entire production process is carried out under the protection of the high-protection hot chamber, reducing the dependence on production personnel. Therefore, it not only ensures the consistency of production efficiency and product quality, but also reduces the burden on personnel and risks.

[0021] In application, a raw material bottle 103 containing radioactive material is fed into the receiving heat chamber 2. The opening mechanism 202 opens the bottle, and then a first robotic arm 205 transfers the opened bottle to the first transfer channel 206. A second robotic arm 303 in the dilution heat chamber 3 transfers the bottle from the first transfer channel 206 to the dilution heat chamber 3 for dilution, obtaining a diluted solution. The diluted solution enters the dispensing station 401 in the dispensing heat chamber 4 through a capillary tube 307 for dispensing, obtaining the final product.

[0022] like Figure 2 As shown, in one embodiment of the present invention, the radioactive liquid drug production line further includes a transfer assembly 1, which is used to transfer the raw material bottle from the warehouse to the receiving hot chamber 2. The transfer assembly 1 includes a trolley 101, on which a first shielding container 102 is provided, and the raw material bottle 103 is placed inside the first shielding container 102. Specifically, the trolley 101 is provided with a lifting frame, and the first shielding container 102 is placed on the lifting frame. Further, the bottom of the receiving hot chamber 2 is provided with a raw material inlet 201; the receiving hot chamber 2 is also provided with a third robotic arm 203 for transferring the shielding container 102 into the receiving hot chamber 2. Iodine-131 is stored in the raw material bottle 103. To avoid the harm caused by the β rays of iodine-131, the raw material bottle 103 needs to be placed in the first shielding container 102.

[0023] In application, a person manually uses a movable trolley 101 to remove the first shielding container 102 from the raw material warehouse and places it on the lifting frame. Then, the trolley 101 is pushed under the receiving heat chamber 2, and the lifting frame raises the first shielding container 102 to dock with the raw material inlet 201. The third robotic arm 203 and the first robotic arm 205, controlled manually or by an automated system, transfer the first shielding container 102 into the receiving heat chamber 2 and remove the raw material bottle 103 from it. Then, the first robotic arm 205 places the raw material bottle 103 on the capping mechanism 202, opens the cap of the raw material bottle 103, and then the first robotic arm 205 places the opened raw material bottle 103 into the first transfer channel 206.

[0024] In one embodiment of the present invention, the dilution hot chamber 3 is further provided with a detection system 305, which is used to detect the concentration of radioactive material (iodine-131) in the raw material bottle 103 and to calculate the required amount of diluent solution. Further, the dilution hot chamber 3 also includes a dilution sampling bottle 207, which is used to test the dilution effect of the diluent; the dilution assembly 301 is also configured to inject the diluent into the dilution sampling bottle 207. In addition, the bottom of the receiving hot chamber 2 is provided with a material inlet 204, which serves as a channel for transferring the dilution sampling bottle 207. The dispensing hot chamber 4 and the dilution hot chamber 3 are connected by a second transfer channel 306.

[0025] During production and application, several dilution sampling bottles 207 can be manually or robotically transferred to the receiving hot chamber 2 through the material inlet 204. Then, a first robotic arm 205 picks up the dilution sampling bottles 207 and places them in the material transfer channel 206 between the hot chambers. A second robotic arm 303 moves them into the dilution hot chamber 3. A fourth robotic arm 304 in the dilution hot chamber 3 transfers the raw material bottle 103 to the dilution assembly 301. The dilution assembly 301 injects a certain amount of iodine-131 diluent into the dilution sampling bottles 207 for testing the dilution effect. If the test is successful, the diluent is transferred through a capillary tube 307 to the dispensing station 401 in the dispensing hot chamber 4 for dispensing to obtain the product.

[0026] In one embodiment of the present invention, the radioactive liquid drug production line further includes a preparation hot chamber 5, which is connected to the dispensing hot chamber 4 via a third transfer channel 407, for providing product vials 50101 to the dispensing hot chamber 4. Further, the dispensing hot chamber 4 has a discharge port 408 at its bottom; the dispensing hot chamber 4 is equipped with a fifth robotic arm 405, a sixth robotic arm 406, a robot 404, and an activity detection system 403 for detecting product activity.

[0027] In application, several empty product vials 50101 are manually assembled onto a tray 501 and then placed in the third transfer channel 407. A robot 404 removes the tray 501 from the preparation heat chamber 5 and places it in a fixed position in the dispensing heat chamber 4. Next, the robot 404 picks up the empty product vials 50101 from the tray 501 and places them onto the dispensing station 401. The dispensing station 401 automatically injects a measured amount of iodine-131 diluent into the product vials 50101 and completes the sealing process, obtaining the product. After dispensing, the robot 404 picks up the sealed product vials 50101 and transfers them into the activity detection system 403 for iodine-131 activity testing. After testing, the robot 404 transfers the product vials 50101 to the discharge port 408 to await discharge. The fifth robotic arm 405 and the sixth robotic arm 406 assist the robot 404 in handling the tray 501 and product vials 50101.

[0028] In one embodiment of the present invention, the radioactive liquid drug production line further includes a discharge system 6, which includes a supply device 601, a robot system 602, and a transfer device 603. The supply device 601 and the transfer device 603 are spaced apart, and the robot system 602 is disposed between the supply device 601 and the transfer device 603. A discharge platform 409 is installed on the side of the dispensing hot chamber 4 near the robot system 602. A rotatable rotary guide rail 410 is provided on the discharge platform 409, and a base 411 is provided on the rotary guide rail 410. The supply device 601 is used to carry the second shielding container 60101, and the robot system 602 is used to transfer the second shielding container 60101 to the base 411 and to transfer the second shielding container 60101, which contains the product bottle 50101, on the base 411 to the transfer device 603; when the base 411 rotates to the point where the second shielding container 60101 is below the discharge port 408, the product bottle 50101 falls into the second shielding container 60101.

[0029] Specifically, during production, the supply device 601 containing the second shielding container 60101 is transferred from the warehouse to a predetermined location by manual labor or automated equipment (such as robots). The robot system 602 automatically grabs an empty second shielding container 60101 and places it on the base 411. The base 411 rotates the second shielding container 60101 to be directly below the discharge port 408 to receive the product medicine bottle 50101. Then, the second shielding container 60101 containing the product medicine bottle 50101 is transferred out. The robot system 602 takes away the second shielding container 60101 containing the product medicine bottle 50101 and places it on the transfer device 603. After the second shielding container 60101 is placed on the transfer device 603, it is manually transferred to the product warehouse for storage.

[0030] In addition, a waste liquid collection system 308 is provided in the dilution hot chamber 3, and the dilution component 301 is connected to the waste liquid collection system 308 through a first discharge pipe 309; the dispensing station 401 is connected to the waste liquid collection system 308 through a second discharge pipe 412. After production, the radioactive waste liquid generated in the dilution hot chamber 3 and the dispensing hot chamber 4 is discharged into the waste liquid collection system 308 through the first discharge pipe 309 and the second discharge pipe 412, respectively, for treatment. A first solid waste collection system 302, a second solid waste collection system 402, and a third solid waste collection system 502 are respectively provided in the raw material dilution hot chamber 3, the dispensing hot chamber 4, and the preparation hot chamber 5; after production, the radioactive solid waste generated in the raw material dilution hot chamber 3, the dispensing hot chamber 4, and the preparation hot chamber 5 is respectively put into the solid waste collection system 302, the solid waste collection system 402, and the solid waste collection system 502 for treatment.

[0031] This invention also provides a method for producing a radioactive liquid drug, using the production line of the radioactive liquid drug in any of the above embodiments to achieve all its effects; the production method includes the following steps: The raw material bottle 103 containing radioactive material is sent into the receiving heat chamber 2, and the raw material bottle 103 is opened by the cap opening mechanism 202; The opened raw material bottle 103 is sent into the dilution hot chamber 3, and the detection system 305 detects the concentration of radioactive raw material in the raw material bottle 103 and calculates the required amount of dilution solution. The raw material bottle 103 is transferred to the dilution assembly 301 for dilution to obtain a diluted solution; the diluted solution is then sent to the dispensing station 401 for dispensing to obtain the product.

[0032] After obtaining the diluent, a portion of the diluent is injected into the sampling bottle 207 to test the dilution effect; if the test is qualified, the diluent is sent to the dispensing station 401 for dispensing.

[0033] After obtaining the product, the product is loaded into the second shielded container 60101 and then discharged.

[0034] The above embodiments are only used to illustrate the technical solutions of the present invention, and are not intended to limit it. Although the present invention has been described in detail with reference to the foregoing embodiments, those skilled in the art should understand that modifications can still be made to the technical solutions described in the foregoing embodiments, or equivalent substitutions can be made to some of the technical features. Such modifications or substitutions do not cause the essence of the corresponding technical solutions to deviate from the spirit and scope of the technical solutions of the embodiments of the present invention, and should all be included within the protection scope of the present invention.

Claims

1. A production line for radiopharmaceutical liquids, characterized in that, It includes a receiving hot chamber (2), a dilution hot chamber (3) and a dispensing hot chamber (4), wherein the receiving hot chamber (2) and the dilution hot chamber (3) are connected by a first transfer channel (206); The receiving hot chamber (2) is used to receive a raw material bottle (103) containing radioactive raw materials; the receiving hot chamber (2) is provided with a cap opening mechanism (202) for opening the raw material bottle (103) and a first manipulator (205) for transferring the raw material bottle (103) to the first transfer channel (206). The dilution chamber (3) is equipped with a second robotic arm (303) and a dilution assembly (301). The second robotic arm (303) is used to transfer the raw material bottle (103) into the dilution chamber (3). The dilution assembly (301) is used to dilute the raw material in the raw material bottle (103) to obtain a diluted solution. The dispensing hot chamber (4) is provided with a dispensing station (401) for dispensing the diluent, and the dispensing station (401) is connected to the dilution component (301) through a capillary tube (307).

2. The line for production of radiopharmaceutical liquids according to claim 1, characterized in that, The radioactive liquid drug production line also includes a transfer assembly (1) for transferring the raw material bottle from the warehouse to the receiving hot chamber (2). The transfer assembly (1) includes a trolley (101) on which a first shielding container (102) is provided, and the raw material bottle (103) is placed inside the first shielding container (102).

3. The production line for radioactive liquid pharmaceuticals according to claim 2, characterized in that, The bottom of the receiving heat chamber (2) is provided with a raw material inlet (201); the receiving heat chamber (2) is also provided with a third robotic arm (203) for transferring the shielding container (102) into the receiving heat chamber (2).

4. The production line for radioactive liquid pharmaceuticals according to claim 1, characterized in that, The dilution chamber (3) is also equipped with a detection system (305), which is used to detect the concentration of radioactive material in the raw material bottle (103) and to calculate the amount of dilution solution required.

5. The production line for radioactive liquid pharmaceuticals according to claim 1, characterized in that, The dilution chamber (3) also contains a dilution sampling bottle (207) for testing the dilution effect of the diluent; the dilution assembly (301) is also configured to inject the diluent into the dilution sampling bottle (207).

6. The production line for radioactive liquid pharmaceuticals according to claim 1, characterized in that, The radioactive liquid drug production line also includes a preparation heat chamber (5), which is connected to the dispensing heat chamber (4) via a third transfer channel (407) and is used to provide product vials (50101) to the dispensing heat chamber (4).

7. The production line for radioactive liquid pharmaceuticals according to claim 6, characterized in that, The production line for the radioactive liquid drug also includes a discharge system (6), which includes a supply device (601), a robot system (602), and a transfer device (603). The supply device (601) and the transfer device (603) are arranged at intervals, and the robot system (602) is arranged between the supply device (601) and the transfer device (603). The bottom of the dispensing hot chamber (4) is provided with a discharge port (408); a discharge platform (409) is installed on the side of the dispensing hot chamber (4) near the robot system (602), and a rotatable rotating guide rail (410) is provided on the discharge platform (409), and a base (411) is provided on the rotating guide rail (410). The supply device (601) is used to carry the second shielding container (60101), the robot system (602) is used to transfer the second shielding container (60101) to the base (411), and to transfer the second shielding container (60101) containing the product bottle (50101) on the base (411) to the transfer device (603); when the base (411) rotates to the position of the second shielding container (60101) below the discharge port (408), the product bottle (50101) falls into the second shielding container (60101).

8. The production line for radioactive liquid pharmaceuticals according to claim 1, characterized in that, The dilution chamber (3) is equipped with a waste liquid collection system (308), and the dilution component (301) is connected to the waste liquid collection system (308) through a first discharge pipe (309); the dispensing station (401) is connected to the waste liquid collection system (308) through a second discharge pipe (412).